Trial | NCT02143349  Report issue

Title

The Effect of Coleus Forskohlii Extract on the Risk Factors of Metabolic Syndrome
Investigation of Appetite Suppressant Properties Associated With Coleus Forskohlii in Overweight and Obese Individuals

  • Phase

    Phase 3

  • Study Type

    Interventional

  • Status

    Unknown status

  • Study Participants

    50
Coleus forskohlii extract contains the bioactive compound, forskolin. Preliminary studies have shown that forskolin can increase fat metabolism thus reduce fat accumulation in both animals and humans. It has been suggested that forskolin may also suppress appetite thus reduce energy intake and results in weight loss. This study will evaluate the appetite suppressant properties of Coleus forskohlii extract. In addition the effect on central obesity and risk factors of metabolic syndrome will also be investigated.
Study Started
Apr 30
2014
Primary Completion
May 31
2015
Anticipated
Study Completion
May 31
2015
Anticipated
Last Update
May 21
2014
Estimate

Dietary Supplement Coleus forskohlii extract

Ingestion of 250 mg Coleus forskohlii extract capsule twice a day for 12 weeks

Other Placebo

Ingestion of 250 mg placebo capsule twice a day for 12 weeks

Coleus forskohlii extract Experimental

Ingestion of 250 mg capsle (Coleus forskohlii extract) twice a day for 12 weeks

Placebo Placebo Comparator

Ingestion of 250 mg capsule (placebo) twice a day for 12 weeks

Criteria 

Inclusion Criteria:

Both Australian males and females, age 20-60 years, Overweight or obese (BMI >25), waist circumference of > 94 cm (male), waist circumference of >80 cm (female)

Exclusion Criteria:

Cigarette smoker, hypertension, all types of heart, liver and kidney disease, pregnancy, lactating, Type 1 diabetes and weight loss medication.
No Results Posted